US-guided microwave ablation for secondary hyperparathyroidism in patients after renal transplantation: a pilot study

References

• Perrin P, Caillard S, Javier RM, et al. Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation. Am J Transplant. 2013;13:2653–2663.
   PubMed Web of Science ®Google Scholar
• Mazzaferro S, Pasquali M, Taggi F, et al. Progression of coronary artery calcification in renal transplantation and the role of secondary hyperparathyroidism and inflammation. Clin J Am Soc Nephrol. 2009;4:685–690.
   PubMed Web of Science ®Google Scholar
• Gwinner W, Suppa S, Mengel M, et al. Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications. Am J Transplant. 2005;5:1934–1941.
   PubMed Web of Science ®Google Scholar
• Komaba H, Moriwaki K, Goto S, et al. Cost-effectiveness of cinacalcet hydrochloride for hemodialysis patients with severe secondary hyperparathyroidism in Japan. Am J Kidney Dis. 2012;60:262–271.
   PubMed Web of Science ®Google Scholar
• Sezer S, Tutal E, Bal Z, et al. Differential influence of vitamin D analogs on left ventricular mass index in maintenance hemodialysis patients. Int J Artif Organs. 2014;37:118–125.
   PubMed Web of Science ®Google Scholar
• Akizawa T, Akiba T, Hirakata H, et al. Comparison of paricalcitol with maxacalcitol injection in Japanese hemodialysis patients with secondary hyperparathyroidism. Ther Apher Dial. 2015;19:225–234.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Li M, You L, et al. Effects and safety of calcimimetics in end stage renal disease patients with secondary hyperparathyroidism: a meta-analysis. PloS One. 2012;7:e48070.
   PubMed Web of Science ®Google Scholar
• Akizawa T, Kido R, Fukagawa M, et al. Decreases in PTH in Japanese hemodialysis patients with secondary hyperparathyroidism: associations with changing practice patterns. Clin J Am Soc Nephrol. 2011;6:2280–2288.
   PubMed Web of Science ®Google Scholar
• Soliman AR, Maamoun HA, Soliman MA, et al. Cinacalcet versus parathyroidectomy in the treatment of secondary hyperparathyroidism post renal transplantation. Rom J Intern Med. 2016;54:184–189.
   PubMed Web of Science ®Google Scholar
• Raggi P, Chertow GM, Torres PU, et al. The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant. 2011;26:1327–1339.
   PubMed Web of Science ®Google Scholar
• Younes M, Belghali S, Zrour-Hassen S, et al. Complete reversal of tumoral calcinosis after subtotal parathyroidectomy in a hemodialysis patient. Joint Bone Spine. 2008;75:606–609.
   PubMed Web of Science ®Google Scholar
• Kim BS, Eom TI, Kang KH, et al. Radiofrequency ablation of parathyroid adenoma in primary hyperparathyroidism. J Med Ultrason (2001). 2014;41:239–243.
   PubMed Web of Science ®Google Scholar
• Diao Z, Liu X, Qian L, et al. Efficacy and its predictor in microwave ablation for severe secondary hyperparathyroidism in patients undergoing haemodialysis. Int J Hyperthermia. 2016;32:614–622.
   PubMed Web of Science ®Google Scholar
• Zhao J, Qian L, Zu Y, et al. Efficacy of ablation therapy for secondary hyperparathyroidism by ultrasound guided percutaneous thermoablation. Ultrasound Med Biol. 2016;42:1058–1065.
   PubMed Web of Science ®Google Scholar
• Chen HH, Lin CJ, Wu CJ, et al. Chemical ablation of recurrent and persistent secondary hyperparathyroidism after subtotal parathyroidectomy. Ann Surg. 2011;253:786–790.
   PubMed Web of Science ®Google Scholar
• Tentori F, Wang M, Bieber BA, et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol. 2015;10:98–109.
   PubMed Web of Science ®Google Scholar
• Yu MA, Yao L, Zhang L, et al. Safety and efficiency of microwave ablation for recurrent and persistent secondary hyperparathyroidism after parathyroidectomy: a retrospective pilot study. Int J Hyperthermia. 2016;32:180–186.
   PubMed Web of Science ®Google Scholar
• Noussios G, Anagnostis P, Natsis K. Ectopic parathyroid glands and their anatomical, clinical and surgical implications. Exp Clin Endocrinol Diabetes. 2012;120:604–610.
   PubMed Web of Science ®Google Scholar
• Roy M, Mazeh H, Chen H, et al. Incidence and localization of ectopic parathyroid adenomas in previously unexplored patients. World J Surg. 2013;37:102–106.
   PubMed Web of Science ®Google Scholar
• Zhuo L, Peng LL, Zhang YM, et al. US-guided microwave ablation of hyperplastic parathyroid glands: safety and efficacy in patients with end-stage renal disease-a pilot study. Radiology. 2017;282:576–584.
   PubMed Web of Science ®Google Scholar
• Adda G, Scillitani A, Epaminonda P, et al. Ultrasound-guided laser thermal ablation for parathyroid adenomas: analysis of three cases with a three-year follow-up. Horm Res. 2006;65:231–234.
   PubMedGoogle Scholar
• Cao XL, Cheng ZG, Yu XL, et al. Ultrasound-guided percutaneous microwave ablation of parathyroid adenoma. J Vasc Interv Radiol. 2016;27:1929–1931.
   PubMed Web of Science ®Google Scholar
• Kovatcheva R, Vlahov J, Stoinov J, et al. US-guided high-intensity focused ultrasound as a promising non-invasive method for treatment of primary hyperparathyroidism. Eur Radiol. 2014;24:2052–2058.
   PubMed Web of Science ®Google Scholar
• Yang J, Hao R, Yuan L, et al. Value of dual-phase (99m)Tc-sestamibi scintigraphy with neck and thoracic SPECT/CT in secondary hyperparathyroidism. AJR Am J Roentgenol. 2014;202:180–184.
   PubMed Web of Science ®Google Scholar
• Wang R, Jiang T, Chen Z, et al. Regression of calcinosis following treatment with radiofrequency thermoablation for severe secondary hyperparathyroidism in a hemodialysis patient. Intern Med. 2013;52:583–587.
   PubMed Web of Science ®Google Scholar
• Baek JH, Lee JH, Valcavi R, et al. Thermal ablation for benign thyroid nodules: radiofrequency and laser. Korean J Radiol. 2011;12:525–540.
   PubMed Web of Science ®Google Scholar
• Monchik JM, Donatini G, Iannuccilli J, et al. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg. 2006;244:296–304.
   PubMed Web of Science ®Google Scholar
• Cardella JF, Kundu S, Miller DL, et al.; Society of Interventional R. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2009;20:S189–S191.
   PubMed Web of Science ®Google Scholar
• Saad WE, Wallace MJ, Wojak JC, et al. Quality improvement guidelines for percutaneous transhepatic cholangiography, biliary drainage, and percutaneous cholecystostomy. J Vasc Interv Radiol. 2010;21:789–795.
   PubMed Web of Science ®Google Scholar
• Torres A, Lorenzo V, Salido E. Calcium metabolism and skeletal problems after transplantation. J Am Soc Nephrol. 2002;13:551–558.
   PubMed Web of Science ®Google Scholar
• Gomes LK, Custodio MR, Contieri FL, et al. Persistent disorders of mineral metabolism after one year of kidney transplantation. J Bras Nefrol. 2016;38:282–287.
   PubMedGoogle Scholar
• Al-Moasseb Z, Aitken E. Natural History of Serum Calcium and Parathyroid Hormone Following Renal Transplantation. Transplant Proc. 2016;48:3285–3291.
   PubMed Web of Science ®Google Scholar
• Pihlstrom H, Dahle DO, Mjoen G, et al. Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism. Transplantation. 2015;99:351–359.
   PubMed Web of Science ®Google Scholar
• Kasiske BL, Zeier MG, Chapman JR, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int. 2010;77:299–311.
   PubMed Web of Science ®Google Scholar
• Torres PU, Prie D, Beck L, et al. New therapies for uremic secondary hyperparathyroidism. J Ren Nutr. 2006;16:87–99.
   PubMed Web of Science ®Google Scholar
• Urena P, Jacobson SH, Zitt E, et al. Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice–the ECHO observational study. Nephrol Dial Transplant. 2009;24:2852–2859.
   PubMed Web of Science ®Google Scholar
• Weisinger JR, Carlini RG, Rojas E, et al. Bone disease after renal transplantation. Clin J Am Soc Nephrol. 2006;1:1300–1313.
   PubMed Web of Science ®Google Scholar
• Messa P, Cafforio C, Alfieri C. Clinical impact of hypercalcemia in kidney transplant. Int J Nephrol. 2011;2011:906832.
   PubMedGoogle Scholar